Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)
China · Delayed Price · Currency is CNY 25.79
-0.41 (-1.56%)
Sep 12, 2025, 3:00 PM CST
SHA:600332 Revenue
Guangzhou Baiyunshan Pharmaceutical Holdings Company had revenue of 19.36B CNY in the quarter ending June 30, 2025, with 6.99% growth. This brings the company's revenue in the last twelve months to 75.78B, down -1.05% year-over-year. In the year 2024, Guangzhou Baiyunshan Pharmaceutical Holdings Company had annual revenue of 74.99B, down -0.69%.
Revenue (ttm)
75.78B
Revenue Growth
-1.05%
P/S Ratio
0.53
Revenue / Employee
2.76M
Employees
28,048
Market Cap
40.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 74.99B | -522.58M | -0.69% |
| Dec 31, 2023 | 75.52B | 4.73B | 6.68% |
| Dec 31, 2022 | 70.79B | 1.77B | 2.57% |
| Dec 31, 2021 | 69.01B | 7.34B | 11.90% |
| Dec 31, 2020 | 61.67B | -3.28B | -5.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 30.15B |
| WuXi AppTec | 41.90B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Sichuan Biokin Pharmaceutical | 441.19M |
| Shanghai United Imaging Healthcare | 10.98B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
| Aier Eye Hospital Group | 21.94B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |